Please use this identifier to cite or link to this item:
Title: Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period
Authors: Duschak, Vilma G 
Keywords: Trypanosoma Cruzi;Enfermedad de Chagas;objetivos de drogas;Patente
Issue Date: 2016
Journal: Recent patents on anti-infective drug discovery 
The American trypanosomiasis, Chagas disease, is a parasitic infection typically spread by triatomine vectors affecting millions of people all over Latin America. Existing chemotherapy is centered on the nitroaromatic compounds benznidazole and nifurtimox that provide unsatisfactory results and substantial side effects. So, the finding and exploration of novel ways to challenge this neglected disease is a main priority.
DOI: 10.2174/1574891X11666161024165304
Appears in Collections:Publicaciones INP

Show full item record

Page view(s)

checked on Jul 4, 2020

Google ScholarTM




Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.